Eltrombopag modulates reactive oxygen species and decreases acute myeloid leukemia cell survival.
Previous studies have demonstrated that the small molecule thrombopoietin (TPO) mimetic, eltrombopag (E), induces apoptosis in acute myeloid leukemia (AML) cells. Here, we sought to define the mechanism of the anti-leukemic effect of eltrombopag. Our studies demonstrate that, at a concentration of 5...
Main Authors: | Anna Kalota, Mary A Selak, Laura A Garcia-Cid, Martin Carroll |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4411049?pdf=render |
Similar Items
-
The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells
by: Shi M, et al.
Published: (2019-09-01) -
Reactive Oxygen Species Rewires Metabolic Activity in Acute Myeloid Leukemia
by: Andrew J. Robinson, et al.
Published: (2021-03-01) -
Vorinostat induces reactive oxygen species and DNA damage in acute myeloid leukemia cells.
by: Luca A Petruccelli, et al.
Published: (2011-01-01) -
Enriching for human acute myeloid leukemia stem cells using reactive oxygen species-based cell sorting
by: Brett M. Stevens, et al.
Published: (2021-03-01) -
Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species
by: Dou J, et al.
Published: (2021-02-01)